Serum Resistin and High-sensitivity C-reactive Protein as Independent Predictors of Vascular Complications in Type 2 Diabetes Mellitus: A Cross-sectional Observational Study at a Tertiary Care Center
Annals of African Medicine · 2026
DOI: 10.4103/aam.aam_428_25 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of African Medicine, 2026. Verfasst von B J Subhashchandra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, JSS Medical College and Hospital, JSSAHER, Mysuru, Karnataka, India. Hauptthemen laut MEDLINE: C-Reactive Protein, Diabetes Mellitus, Type 2, Resistin, Myocardial Infarction. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Serum resistin has been implicated in atherosclerosis and vascular smooth muscle dysfunction through inflammatory pathways, making it a potential biomarker for cardiovascular risk. Comparative data in diabetic patients with acute vascular events are limited. This study evaluates serum resistin and high-sensitivity C-reactive protein (hs-CRP) levels in type 2 diabetes mellitus (T2DM) with acute myocardial infarction (AMI) or acute ischemic stroke (AIS) to explore their association with vascular complications. Materials and Methods: A cross-sectional, hospital-based study was conducted among T2DM patients presenting with AMI or AIS. Serum resistin, hs-CRP, glycated hemoglobin (HbA1c), lipid profile, and body mass index (BMI) were evaluated, and their associations with vascular events were statistically analyzed, considering P < 0.05 as statistically significant.
Results
The mean serum resistin was significantly higher in the diabetes mellitus (DM) with AMI group (23.21 ± 5.65 ng/ml; P < 0.001) compared to controls (13.30 ± 2.94 ng/ml) but not in the DM with AIS group (19.90 ± 5.46 ng/ml; P = 0.215). hs-CRP was significantly elevated in both DM with AMI and AIS groups (3.43 ± 0.70 mg/l and 3.43 ± 1.01 mg/l, respectively) compared to controls (2.43 ± 0.62 mg/l; both P < 0.001). Positive correlations were observed between these biomarkers and conventional risk factors, including HbA1c, BMI, and low-density lipoprotein cholesterol.
Conclusion
Elevated serum resistin (notably in AMI) and hs-CRP (in both AMI and AIS) in T2DM patients highlight a strong association between inflammation and acute vascular events. These biomarkers may serve as accessible tools for early risk stratification and targeted preventive strategies in high-risk diabetic populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Medicine, JSS Medical College and Hospital, JSSAHER, Mysuru, Karnataka, India.
- Department of General Medicine, MAPIMS, Chennai, Tamil Nadu, India.
- Department of General Medicine, Sree Narayana Institute of Medical Sciences, Kochi, Kerala, India.
Zitieren
APA
Subhashchandra, B. J., Prasad, M. C., Gowd, B. P., & Jacob, B. S. (2026). Serum Resistin and High-sensitivity C-reactive Protein as Independent Predictors of Vascular Complications in Type 2 Diabetes Mellitus: A Cross-sectional Observational Study at a Tertiary Care Center. Annals of African Medicine. https://doi.org/10.4103/aam.aam_428_25
Vancouver
Subhashchandra BJ, Prasad MC, Gowd BP, Jacob BS. Serum Resistin and High-sensitivity C-reactive Protein as Independent Predictors of Vascular Complications in Type 2 Diabetes Mellitus: A Cross-sectional Observational Study at a Tertiary Care Center. Annals of African Medicine. 2026. doi:10.4103/aam.aam_428_25
BibTeX
@article{Subhashchandra2026,
author = {Subhashchandra, B J and Prasad, M C and Gowd, Bhaskar Prakash and Jacob, Baiju Sam},
title = {Serum Resistin and High-sensitivity C-reactive Protein as Independent Predictors of Vascular Complications in Type 2 Diabetes Mellitus: A Cross-sectional Observational Study at a Tertiary Care Center},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_428_25}
}
EUVIMED